Erste Asset Management Gmb H Scholar Rock Holding Corp Transaction History

Erste Asset Management Gmb H

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Nov 22, 2024	SELL	$11.89 - $24.68 $122,467 - $254,204	-10,300 Closed	0 $0
Q4 2021 Nov 22, 2024	BUY	$24.14 - $35.18 $248,642 - $362,354	10,300 New	10,300 $266 Million
Q4 2020 Nov 22, 2024	BUY	$13.72 - $51.57 $141,316 - $531,171	10,300 New	10,300 $490 Million

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.